ID: MRFR/Pharma/4394-HCR | | Region : Global
Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Delirium Market, by Type
6.1 Introduction
6.2 Hyperactive
6.2.1 Market Estimates & Forecast, 2020β2027
6.3 Hypoactive
6.3.1 Market Estimates & Forecast, 2020β2027
6.4 Mixed
6.4.1 Market Estimates & Forecast, 2020β2027
7. Global Delirium Market, by Diagnosis
7.1 Introduction
7.2 Laboratory Tests
7.2.1 Blood Tests
7.2.2 Urine Tests
7.2.3 Market Estimates & Forecast, 2020β2027
7.3 Imaging Tests
7.3.1 Brain-imaging tests
7.3.2 Market Estimates & Forecast, 2020β2027
7.4 Physical Examination
7.4.1 Market Estimates & Forecast, 2020β2027
8. Global Delirium Market, by Treatment
8.1 Introduction
8.2 Antipsychotics
8.2.1 Risperidone
8.2.2 Olanzapine
8.2.3 Quetiapine
8.2.4 Market Estimates & Forecast, 2020β2027
8.3 Supportive Care
8.3.1 Market Estimates & Forecast, 2020β2027
9. Global Delirium Market, by End U.S.er
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2020β2027
9.3 Specialty Centers
9.3.1 Market Estimates & Forecast, 2020β2027
9.4 Research Centers
9.4.1 Market Estimates & Forecast, 2020β2027
10 Global Delirium Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Dr. Franz Kohler Chemie GmbH
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Fraser Health
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Gaia BioPharma Ltd.
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Novartis AG
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Pfizer, Inc.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Regenstrief Institute, Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Air Liquide Sante International.
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOβs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of the Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Delirium Industry Synopsis, 2020β2027
Table 2 Global Delirium Market Estimates & Forecast, 2020β2027, (USD Million)
Table 3 Global Delirium Market, by Region, 2020β2027, (USD Million)
Table 5 Global Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 6 Global Delirium Market, by Diagnosis, 2020β2027, (USD Million)
Table 7 Global Delirium Market, by End-User, 2020β2027, (USD Million)
Table 8 North America Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 9 North America Delirium Market, by Diagnosis, 2020β2027, (USD Million)
Table 10 North America Delirium Market, by End-User, 2020β2027, (USD Million)
Table 11 U.S. Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 12 U.S. Delirium Market, by Diagnosis, 2020β2027, (USD Million)
Table 13 U.S. Delirium Market, by End-User, 2020β2027, (USD Million)
Table 14 Canada Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 15 Canada Delirium Market, by Diagnosis, 2020β2027, (USD Million)
Table 16 Canada Delirium Market, by End-User, 2020β2027, (USD Million)
Table 17 South America Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 18 South America Delirium Market, by Diagnosis, 2020β2027, (USD Million)
Table 19 South America Delirium Market, by End-User, 2020β2027, (USD Million)
Table 20 Europe Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 21 Europe Delirium Market, by Diagnosis, 2020β2027, (USD Million)
Table 22 Europe Delirium Market, by End-User, 2020β2027, (USD Million)
Table 23 Western Europe Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 24 Western Europe Delirium Market, by diagnosis, 2020β2027, (USD Million)
Table 25 Western Europe Delirium Market, by End-User, 2020β2027, (USD Million)
Table 26 Eastern Europe Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 27 Eastern Europe Delirium Market, by diagnosis, 2020β2027, (USD Million)
Table 28 Eastern Europe Delirium Market, by End-User, 2020β2027, (USD Million)
Table 29 Asia Pacific Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 30 Asia Pacific Delirium Market, by diagnosis, 2020β2027, (USD Million)
Table 31 Asia Pacific Delirium Market, by End-User, 2020β2027, (USD Million)
Table 32 Middle East & Africa Delirium Market, by Treatment, 2020β2027, (USD Million)
Table 33 Middle East & Africa Delirium Market, by diagnoses, 2020β2027, (USD Million)
Table 34 Middle East & Africa Delirium Market, by End-User, 2020β2027, (USD Million)
β
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for the Global Delirium Market
Figure 3 Segmentation Market Dynamics for the Delirium Market
Figure 4 Global Delirium Market Share, by Treatment 2020
Figure 5 Global Delirium Market Share, by Diagnosis 2020
Figure 6 Global Delirium Market Share, by End-User, 2020
Figure 7 Global Delirium Market Share, by Region, 2020
Figure 8 North America Delirium Market Share, by Country, 2020
Figure 9 Europe Delirium Market Share, by Country, 2020
Figure 10 Asia Pacific Delirium Market Share, by Country, 2020
Figure 11 Middle East & Africa Delirium Market Share, by Country, 2020
Figure 12 Global Delirium Market: Company Share Analysis, 2020 (%)
Figure 13 Dr. Franz Kohler Chemie GmbH: Key Financials
Figure 14 Dr. Franz Kohler Chemie GmbH: Segmental Revenue
Figure 16 Dr. Franz Kohler Chemie GmbH: Geographical Revenue
Figure 17 Novartis AG: Key Financials
Figure 18 Novartis AG: Segmental Revenue
Figure 19 Novartis AG: Geographical Revenue
Figure 20 Avicena Inc.: Key Financials
Figure 21 Avicena Inc.: Segmental Revenue
Figure 22 Avicena Inc. Geographical Revenue
Figure 23 Pfizer, Inc.: Key Financials
Figure 24 Pfizer, Inc.: Segmental Revenue
Figure 25 Pfizer, Inc.: Geographical Revenue
Figure 26 Regenstrief Institute: Key Financials
Figure 27 Regenstrief Institute: Segmental Revenue
Figure 28 Regenstrief Institute. Geographical Revenue
Figure 29 Air Liquide Sante International.: Key Financials
Figure 30 Air Liquide Sante International.: Segmental Revenue
Figure 31 Air Liquide Sante International.: Geographical Revenue
Figure 32 Gaia BioPharma Ltd.: Key Financials
Figure 33 Gaia BioPharma Ltd.: Segmental Revenue
Figure 34 Gaia BioPharma Ltd.: Geographical Revenue
$287.5 Million
4.4%
North America
2022-2030